VIVODYNE
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies. Its platform cultures the most realistic human tissues ever lab-grown to answer deep questions about human health.
VIVODYNE
Social Links:
Industry:
Biotechnology Lifestyle Medical
Founded:
2020-01-01
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.vivodyne.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
40 M USD
Technology used in webpage:
Domain Not Resolving Cloudflare Hosting Facebook Sharer U.S. Server Location HSTS IncludeSubdomains PreLoad Amazon SSL Next.js Apollo GraphQL Auth0 Chakra UI
Similar Organizations
Aspect Biosystems
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
Clarapath
We are a medical robotics company developing the SectionStar, a platform to mimic the human histotechnician.
Modicus Prime
Bringing Self-Service AI to the Life Sciences
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Serve Robotics
Serve Robotics develops self-driving robots to deliver food and supplies.
Virgin Pulse
Virgin Pulse is a software company that offers services in employee engagement, productivity, employee health, and workplace wellness.
Current Employees Featured
Founder
Investors List
Kairos Ventures
Kairos Ventures investment in Seed Round - Vivodyne
Khosla Ventures
Khosla Ventures investment in Seed Round - Vivodyne
CS Venture Opportunities Fund
CS Venture Opportunities Fund investment in Seed Round - Vivodyne
MBX Capital
MBX Capital investment in Seed Round - Vivodyne
Bison Ventures
Bison Ventures investment in Seed Round - Vivodyne
Kairos Ventures
Kairos Ventures investment in Seed Round - Vivodyne
Key Employee Changes
| Date | New article |
|---|---|
| 2024-01-31 | Vivodyne Appoints Elliot Menschik, M.D., Ph.D., as Chief Technology Officer |
Official Site Inspections
http://www.vivodyne.com Semrush global rank: 5.46 M Semrush visits lastest month: 1.35 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Vivodyne"
Vivodyne - Crunchbase Company Profile & Funding
Vivodyne develops lifelike human organs for drug testing and research purposes. The company utilizes robotic systems and artificial intelligence to create realistic human tissues that simulate various organ functions. ... The … See details»
Vivodyne 2025 Company Profile: Valuation, Funding & Investors
Vivodyne General Information Description. Developer of a platform designed to provide a more accurate and efficient method for preclinical drug testing. The company's platform utilizes lab … See details»
Vivodyne - 2025 Company Profile, Funding & Competitors - Tracxn
May 30, 2025 Vivodyne is a series A company based in Philadelphia (United States), founded in 2021 by Dan Huh. It operates as a Developer of AI-based platform for lab-grown human tissues. … See details»
Vivodyne Company Profile - Office Locations, Competitors ... - Craft
Vivodyne has 5 employees at their 1 location and $42 m in total funding,. See insights on Vivodyne including office locations, competitors, revenue, financials, executives, subsidiaries and more at … See details»
Vivodyne to Replace Animal Testing With $40 Million Funding to …
May 29, 2025 Vivodyne Chief Operating Officer Julie O'Shaughnessy (L) and Vivodyne CEO Andrei Georgescu (R). 95% of clinical trials fail because animal testing is no substitute for human biology … See details»
Vivodyne - A Kairos Ventures Portfolio Company
Vivodyne is changing how scientists study human biology & develop therapeutics. Their platform technology creates a new preclinical drug development pipeline – Pipeline V – that starts and ends in lab-grown human … See details»
This Startup Raised $38 Million To Fill One Of The …
Nov 22, 2023 Vivodyne CEO Andrei Georgescu (L) and Chief Commercial Officer Susan Billings (R). VivoDyne. Only about 10% of drugs in development ever make it to market. That number has remained largely ... See details»
Vivodyne | F6S
Vivodyne software Vivodyne Platform Health/Medical Biotech Robotics AI (Artificial Intelligence) Drug Discovery High-Throughput Screening Predictive AI Preclinical Testing Lab-Grown Human … See details»
About Us - Vivodyne
At Vivodyne, Andrew spearheads the development and implementation of cutting-edge robotic technology crucial for advancing human organ tissue production for drug discovery. Previously, he played pivotal roles in … See details»
Mission, Vision & Core Values of Vivodyne
Dec 7, 2024 At Vivodyne, our mission statement plays a crucial role in driving innovation within our organization. Our mission to develop an automated robotic system that discovers life-changing … See details»
Vivodyne raises $40 million in funding round led by Khosla Ventures
May 29, 2025 Vivodyne has raised about $78 million to date, after a $38 million seed round in 2023. CEO Andrei Georgescu wouldn't disclose Vivodyne's valuation but said it grew significantly with … See details»
This startup is solving the biggest problems in drug development
Dec 9, 2023 While Vivodyne isn’t the first group to create lab-grown human tissues for drug testing, it has figured out how to automate and dramatically scale the process — its robotic platform can … See details»
Careers - Vivodyne
As a team, every corner of the organization brings their insights and ideas to the table. The winning solutions are always based on their ability to accelerate our capabilities, not politics or hierarchy. … See details»
Vivodyne raised $38 million to fill drug discovery gap - Forbes Australia
Nov 22, 2023 Vivodyne’s key technological innovation, Georgescu says, is the ability to grow 22 different types of human tissue that can be used to model blood flow and other interactions … See details»
Vivodyne to Replace Animal Testing With $40 Million Funding to …
About Vivodyne Vivodyne is rendering inaccurate animal testing obsolete, using automated robotic platforms and AI to grow and analyze thousands of fully functional human tissues. … See details»
Vivodyne to Replace Animal Testing With $40 Million Funding
May 29, 2025 Vivodyne has raised $40 million in new Series A financing to scale its robotics+AI approach to testing on thousands of lab-grown, fully-functional human tissues, and the massive … See details»
Vivodyne Raises $38M in Seed Funding to Advance Lab-Grown …
Nov 22, 2023 Vivodyne’s innovative platform seeks to address one of the major bottlenecks in drug development, offering a solution for gathering human-predictive data that is both realistic and … See details»
Vivodyne raised $40 million from Khosla Ventures and others
4 days ago Vivodyne, a Penn spinout that creates human tissue to replace animal testing in drug development, has raised $40 million in a second round of venture capital investment. The … See details»
Our Platform - Vivodyne
Vivodyne Announces Another $40M in Series A Financing. Platform. Platform. Overview. ... Our 3D human tissues are designed to reconstitute the cellular, tissue, organ, and systemic organization … See details»
Vivodyne - Partnerships
Vivodyne Announces Another $40M in Series A Financing. Platform. Platform. Overview. Our platform accelerates the development of new therapies with preclinical human data. learn more. … See details»